News | ECG | February 16, 2021

New ECG System Eliminated Wire Leads to Simplify Standard 12-Lead ECG 

Company says it reduces patient contact during the COVID-19 pandemic and is the world’s first 12-lead ECG service for home use

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.


February 16, 2021 — QT Medical recently announced the launch of Xpress ECG service, the world’s first 12-lead ECG home test, to help reduce the risk of exposure to COVID-19 by bringing ECG tests to patients’ homes. The 12-lead ECG (EKG) with PCA 500 and makes it available for use by both healthcare professionals and patients. 

In response to the surge of needs in the COVID-19 pandemic, the company offers Xpress ECG service, which makes ECG tests accessible and affordable, while decreasing the risk of exposure to potential infections. The physicians can now simply order Xpress ECG tests online and the ECG kits will be shipped to the patients in 1 to 3 business days.

The ECG tests are performed using PCA 500, a complete 12-lead ECG platform that includes a super-compact recorder, prepositioned electrode strip, mobile app, HIPAA-compliant cloud and preliminary interpretation. 

“This new exclusive service offers patients the ability to monitor their own heart health, allows healthcare providers to continue providing quality of care while maximizing revenue, and minimizing cost and risks for the healthcare system. Xpress ECG enables millions of patients with heart diseases to manage their health from the comfort of their homes,” said Ruey-Kang Chang, M.D., CEO of QT Medical Inc.

With the new CPT codes (e.g. 99457), an ECG test done by patients at home can be reimbursed 3 times higher than an ECG test done in the doctor’s office. When the doctor orders an Xpress ECG test, a kit including a PCA 500 recorder, an electrode strip, and a postage-paid return envelope will be shipped to the patients. QT Medical had previously conducted a clinical trial, which showed minimal or no training is needed to use PCA 500. All ECGs are automatically transmitted to the cloud, and a preliminary computer interpretation is instantly available. Through the cloud, physicians can review the results from anywhere to make informed decisions.

Unlike dozens of single lead ECG devices on the market, PCA 500 is hospital grade 12-lead ECG, which is medical standard for diagnosing a wide variety of heart diseases such as heart attacks, long QT syndrome, myocarditis, adverse effects of medications, cardiomyopathy, etc. Using Xpress ECG, healthcare providers can minimize the risk of infection by not sending patients to labs or hospitals for ECG tests. Telehealth patients who need an ECG test will be able to get a full 12-lead ECG without leaving their homes.

Xpress ECG is a medical standard 12-lead ECG test, using PCA 500, ordered by healthcare providers. Patients should consult their physicians to decide if PCA 500 is right for them.

QT Medical is a medtech company with a focus on high quality 12-lead diagnostic ECG for use by healthcare professionals and patients. Cleared by the FDA in 2018 and CE marked in 2020, PCA 500 is the world’s most compact 12-lead ECG system. With its simplicity, ease of use, mobile technology and cloud management, PCA 500 brings hospital-grade ECG to homes, and enables doctors to make informed decisions anywhere, anytime. 

For more information: www.qtmedical.com

Related Content

News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
News | Cardiac Diagnostics

October 4, 2021 – Nanowear, a hospital-at-home and remote diagnostic platform that used proprietary wearable cloth ...

Home October 04, 2021
Home
News | Cardiac Diagnostics

September 28, 2021 — Biotricity Inc., a medical diagnostic and consumer healthcare technology company, has developed a ...

Home September 28, 2021
Home
News | Cardiac Diagnostics

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

Home July 29, 2021
Home
News | Cardiac Diagnostics

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
News | Cardiac Diagnostics

March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potential ...

Home March 08, 2021
Home
News | Cardiac Diagnostics

March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management ...

Home March 03, 2021
Home
News | Cardiac Diagnostics

February 2, 2021 — A new study has found in the U.S. shows higher economic prosperity was associated with a small ...

Home February 02, 2021
Home
News | Cardiac Diagnostics

January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects ...

Home January 06, 2021
Home
Subscribe Now